(Q34094634)

31 July 2017

1 reference

title

Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment (English)

1 reference

31 July 2017

Schlegel U

1

1 reference

31 July 2017

Schmidt-Wolf IG

series ordinal

2

1 reference

31 July 2017

Deckert M

series ordinal

3

1 reference

31 July 2017

publication date

1 December 2000

1 reference

Journal of the Neurological Sciences

31 July 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

31 July 2017

volume

181

1 reference

31 July 2017

issue

1-2

1 reference

31 July 2017

page(s)

1-12

1 reference

Classification, pathogenesis and molecular pathology of primary CNS lymphomas

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Further evidence that "malignant angioendotheliomatosis" is an angiotropic large-cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Angiotropic intravascular large-cell lymphoma with massive cerebral extension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

AIDS-associated non-Hodgkin lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Increasing incidence of primary brain lymphoma in the US

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Primary central nervous system lymphomas in patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Epidemiology of primary CNS lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Primary central nervous system lymphoma: from clinical presentation to diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Primary lymphoma of the central nervous system. Clinicopathological study of experience at Stanford

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Primary cerebral malignant non-Hodgkin's lymphomas: a retrospective clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Primary central nervous system lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Primary CNS lymphoma: findings outside the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Primary Central Nervous System Lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Primary intracerebral malignant lymphoma: report of 248 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Central nervous system lymphoma: histologic types and CT appearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

CT and MR imaging in primary cerebral non-Hodgkin's lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Primary central nervous system lymphoma versus toxoplasmosis in AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Leptomeningeal tumor in primary central nervous system lymphoma: recognition, significance, and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Primary leptomeningeal lymphoma: report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Apoptosis and apoptosis-related gene products in primary non-Hodgkin's lymphoma of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

T-cell lymphoma in the CNS: clinical and pathologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Pathogenesis and classification of primary central nervous system lymphoma: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Comparison of integrin adhesion molecules expressed by primary brain lymphomas and nodal lymphomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

VH4-21, a human VH gene segment overrepresented in the autoimmune repertoire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Utilization of the VH4-21 Gene Segment by Anti-DNA Antibodies from Patients with Systemic Lupus Erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Differential usage of an autoantibody-associated VH gene, VH4-21, by human B-cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Do superantigens play a role in lymphoproliferation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Human antibody responses to bacterial antigens: studies of a model conventional antigen and a proposed model B cell superantigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Primary central nervous system malignant non-Hodgkin's lymphomas from HIV-infected and non-infected patients: expression of cellular surface proteins and Epstein-Barr viral markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Human herpesvirus-6 and Epstein-Barr virus genome in primary cerebral lymphomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Human herpesvirus 8 DNA in CNS lymphomas from patients with and without AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

HHV-8/KSHV is not associated with AIDS-related primary central nervous system lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

HHV-8 and AIDS-related CNS lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Involvement of the bcl-2 gene in human follicular lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

The propensity to apoptosis of centrocytes and centroblasts correlates with elevated levels of intracellular myc protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Primary central nervous system lymphomas. Immunophenotypic, virologic, and cytogenetic findings of three patients without immune defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Chromosomal imbalances in primary lymphomas of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Glucocorticoid treatment of primary CNS lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Sentinel lesions of primary CNS lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Glucocorticoid-induced long-term remission in primary cerebral lymphoma: case report and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Primary lymphoma of brain: results of management of a modern cohort with radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Management of primary cerebral lymphoma with initial chemotherapy: Preliminary results and comparison with patients treated with radiotherapy alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Rapid infusion of high-dose methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Chemotherapy is effective as early treatment for primary central nervous system lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Combined modality therapy for primary CNS lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Long-term survival in primary CNS lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: response to therapy and quality of life of patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Prevention of recurrence and prolonged survival in primary central nervous system lymphoma (PCNSL) patients treated with adjuvant high-dose methylprednisolone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Additional experience with empiric radiotherapy for presumed human immunodeficiency virus-associated primary central nervous system lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Primary central nervous system lymphoma: a role for adjuvant chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Involved-field radiotherapy and intra-Ommaya methotrexate/cytarabine in patients with AIDS-related lymphomatous meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Neurologic sequelae of treatment of primary CNS lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

Characteristic chromosomal imbalances in primary central nervous system lymphomas of the diffuse large B-cell type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900385-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(00)00385-3

1 reference

31 July 2017

1 reference